Literature DB >> 27624553

A case of small intestinal endometrioid adenocarcinoma.

Yusuke Ogi1, Tomohiro Yamaguchi2, Yusuke Kinugasa1, Akio Shiomi1, Hiroyasu Kagawa1, Yushi Yamakawa1, Masakatsu Numata1, Akinobu Furutani1, Masakazu Abe3.   

Abstract

Endometriosis generally occurs in the ovary. Intestinal endometriosis is rare. About 1 % of all endometriosis cases become malignant. Malignant transformation of small intestinal endometriosis is very rare. A 55-year-old woman who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy and omentectomy for endometriosis 7 years ago presented to her primary care doctor with melena. A tumor was detected in the right lower abdomen by ultrasonography. The doctor referred her to our hospital. Computed tomography demonstrated a lobulated tumor ventral to the right common iliac vessels. Magnetic resonance imaging demonstrated that the tumor had heterogeneous intensity on T2-weighted images. Several small cysts with high intensity were observed caudal to the tumor on T2-weighted images. We performed partial small intestinal resection for the lesion. The tumor was diagnosed as endometrioid adenocarcinoma of the small intestine. She has been relapse-free for 5 years after surgery. Only three cases of malignant transformation of small intestinal endometriosis have been reported previously. It is very rare for long-term survival to be obtained with surgery alone, as in our case. This case report highlights the imaging findings for malignant transformation of intestinal endometriosis.

Entities:  

Keywords:  Endometriosis; Magnetic resonance imaging; Malignant transformation; Small intestine

Year:  2016        PMID: 27624553      PMCID: PMC5021644          DOI: 10.1186/s40792-016-0226-6

Source DB:  PubMed          Journal:  Surg Case Rep        ISSN: 2198-7793


Background

Endometriosis generally occurs in the ovary. It rarely involves the intestinal tract. Almost all reported cases of intestinal endometriosis involve the sigmoid colon and rectum [1]. There have been relatively few reports of endometriosis in the small intestine. Malignant transformation occurs in approximately 1 % of all endometriosis cases [2]. We report a very rare case of endometrioid adenocarcinoma, which is endometriosis with malignant transformation, in the small intestine.

Case presentation

A 55-year-old woman presented to her primary care doctor with melena. A tumor in the right lower abdomen was detected by ultrasonography. The doctor referred her to our hospital for further examination and treatment. She underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy and omentectomy for endometriosis 7 years ago. On physical examination, a tumor was slightly palpable in the right lower abdomen. Computed tomography of the abdomen demonstrated a 6.5 × 4 cm lobulated tumor ventral to the right common iliac vessels. Enlarged lymph nodes were observed in the area of the ileocolic artery. She also underwent a contrast-enhanced magnetic resonance (MR) imaging examination. The tumor had intermediate signal intensity, similar to that of muscle, on T1-weighted images and heterogeneous intensity on T2-weighted images. On contrast-enhanced MR images with gadolinium, the mass was enhanced heterogeneously. Several small cysts that were hypointense on T1-weighted images and hyperintense on T2-weighted images were observed caudal to the tumor (Fig. 1).
Fig. 1

MR imaging. a T2-weighted imaging. A lobulated tumor was observed ventral to the right common iliac artery. The tumor had heterogeneous intensity. b, c T2-weighted imaging. Some high-intensity cystic lesions (arrow) were detected around the tumor. d T1-weighted imaging. The mass had heterogeneous enhancement (arrowheads indicate the outline of the tumor)

MR imaging. a T2-weighted imaging. A lobulated tumor was observed ventral to the right common iliac artery. The tumor had heterogeneous intensity. b, c T2-weighted imaging. Some high-intensity cystic lesions (arrow) were detected around the tumor. d T1-weighted imaging. The mass had heterogeneous enhancement (arrowheads indicate the outline of the tumor) Blood tests revealed anemia, with a hemoglobin concentration of 8.5 g/dL. Serum concentrations of carcinoembryonic antigen and carbohydrate antigen 125 were 1.7 ng/mL and 14 U/mL, respectively. Endoscopic examination did not detect any tumors or sites of bleeding in the colon. We suspected primary small intestinal cancer, a retroperitoneal tumor with invasion to the small bowel, or endometriosis with malignant transformation. Surgery was performed. Intraoperatively, we observed that the tumor was located ventral to the right common iliac vessels. Because the tumor invaded the ileum 35 cm proximal to the end of the ileum, we performed partial small intestinal resection (Fig. 2).
Fig. 2

Macroscopic findings. The tumor (arrows) invaded the intestinal mucosa

Macroscopic findings. The tumor (arrows) invaded the intestinal mucosa Histologically, the tumor penetrated to the mucosa of the small intestine. The tumor consisted of two types of stromal tissue (endometriosis type and ovarian type) and atypical endometrioid glandular epithelium. The atypical cells were immunopositive for cytokeratin 7 but were negative for cytokeratin 20. The histopathological diagnosis was endometrioid adenocarcinoma (Fig. 3). The stromal tissues in the wall of the small intestine surrounded the adenocarcinoma component. The endometrioid adenocarcinoma was localized in the intestinal wall. Small intestinal endometriosis was considered the site of malignant transformation. There was no lymph node metastasis. Postoperative chemotherapy was not performed. She has been relapse-free for 5 years after surgery.
Fig. 3

Microscopic findings. Sixteen tumor cells had nuclear atypia and irregular glandular structures (hematoxylin-eosin 17 stain, ×40)

Microscopic findings. Sixteen tumor cells had nuclear atypia and irregular glandular structures (hematoxylin-eosin 17 stain, ×40)

Discussion

The clinical course of this patient illustrates two important clinical points. Malignant transformation of endometriosis can occur in the small intestine. MR imaging is useful in the diagnostic evaluation of malignant endometriosis in the small intestine. First, malignant transformation of endometriosis can occur in the small intestine. The ovary is the site of 80 % of all endometriosis cases. Abdominal endometriosis accounts for 5.3 to 12 % of endometriosis [3]. Intestinal endometriosis mainly occurs in the sigmoid colon and rectum, and these two sites account for 77 % of abdominal endometriosis [1]. About 1 % of all endometriosis cases become malignant [2]. Only three cases of malignant endometriosis in the small intestine have been reported (Table 1) [4-6]. It is very rare for long-term survival to be obtained with surgery alone, as in our case.
Table 1

Reports of endometriosis with malignant transformation in the small intestine

CaseAuthorYearAgePast surgical historyHistologyPostoperative therapySurvivalReference
1Ferraro et al.1956441. Left partial oophorectomy for endometriosisEndometriotic sarcomaRadiation therapyDied of disease 4 months after surgery[4]
2. Right oophorectomy for corpus luteum cyst
3. Supravaginal hysterectomy for fibromyoma
4. Removal of a right intraligamentous chocolate cyst with endometriosis
5. Colon resection for pelvic endometrioma
2Baiocchii et al.199038TAH and BSO for endometriosisEndometrioid stromal sarcomaChemotherapyNo contributions[5]
3Makihara et al.201525NoneEndometrioid adenocarcinomaNoneDisease-free for 10 months[6]
4Present case201655TAH and BSO and omentectomy for endometriosisEndometrioid adenocarcinomaNoneDisease-free for 5 years

TAH total abdominal hysterectomy, BSO bilateral salpingo-oophorectomy

Reports of endometriosis with malignant transformation in the small intestine TAH total abdominal hysterectomy, BSO bilateral salpingo-oophorectomy Second, MR imaging is useful for diagnosing malignant endometriosis in the small intestine. Endometriosis in the rectum is often assessed with MR imaging, with very high diagnostic accuracy. Compared to rectal endometriosis, the diagnostic accuracy of intestinal endometriosis with MR imaging is lower [7]. Endometriosis in the acute phase is characterized by high signal intensity on both T1- and T2-weighted images, which is suggestive of the presence of subacute hemorrhage. During the chronic phase, shading, which is defined as a centrally or peripherally located low-intensity area in a hyperintense cyst, can be observed on T2-weighted images [8]. If solid nodules exist in a cyst, there is a possibility of malignant transformation. Contrast-enhanced MR imaging with gadolinium is considered when solid components of endometriosis are suspected to be malignant. In the study of mural nodules within cysts, malignant endometriosis is characterized by the lack of shading on T2-weighted images, high signal intensity on diffusion-weighted images, and heterogeneous enhancement on MR images with contrast [9]. In our case, the tumor had surrounding small cysts with low intensity on T1-weighted images, heterogeneous intensity on T2-weighted images, and heterogeneous enhancement on T1-weighted images with contrast. Small cysts are considered to reflect endometriosis, while heterogeneous enhancement on T1-weighted images reflects malignant transformation. In patients with a history of endometriosis, when a tumor with cysts is detected, we need to consider the possibility of malignant transformation arising from intestinal endometriosis. Contrast-enhanced MR imaging may be useful in the diagnostic evaluation of malignant endometriosis in the small intestine. Surgical resection is the first-choice treatment for malignant endometriosis. Lymph node metastasis and peritoneal dissemination have been reported to be poor prognostic factors [10, 11]. Patients with either factor may benefit from postoperative chemotherapy. In the case of endometrioid adenocarcinoma of the ovary, the recommended postoperative chemotherapy regimen is carboplatin plus paclitaxel [12, 13]. If the tumor is localized and well differentiated and there is no lymph node metastasis, postoperative chemotherapy may be omitted in ovarian cancer. However, the evidence base for postoperative chemotherapy to treat intestinal malignant endometriosis has not been fully established because of the small number of cases. In the present case, endometrioid adenocarcinoma was localized to the intestinal wall, resection margins were negative, and complete resection was performed. There was no lymph node metastasis and histological examination showed that the tumor was well differentiated. We consulted with the patient and decided not to perform postoperative chemotherapy.

Conclusions

Malignant endometriosis can arise in the small intestine and MR imaging is useful for diagnosing endometriosis with malignant transformation. Although there is a need to accumulate more cases, we propose that contrast-enhanced MR imaging is useful for detecting malignant transformation of intestinal endometriosis.
  13 in total

1.  A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

Authors:  Andreas du Bois; Hans-Joachim Lück; Werner Meier; Hans-Peter Adams; Volker Möbus; Serban Costa; Thomas Bauknecht; Barbara Richter; Matthias Warm; Willibald Schröder; Sigrid Olbricht; Ulrike Nitz; Christian Jackisch; Günther Emons; Uwe Wagner; Walther Kuhn; Jacobus Pfisterer
Journal:  J Natl Cancer Inst       Date:  2003-09-03       Impact factor: 13.506

2.  Present conception of endometriosis and its treatment.

Authors:  J C MASSON
Journal:  Collect Papers Mayo Clinic Mayo Found       Date:  1946-07

3.  Endometrial cysts of the ovary: MR imaging.

Authors:  K Nishimura; K Togashi; K Itoh; I Fujisawa; S Noma; Y Kawamura; Y Nakano; H Itoh; K Torizuka; H Ozasa
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

Review 4.  Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literature.

Authors:  G Baiocchi; J J Kavanagh; J T Wharton
Journal:  Gynecol Oncol       Date:  1990-01       Impact factor: 5.482

5.  Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Authors:  Robert F Ozols; Brian N Bundy; Benjamin E Greer; Jeffrey M Fowler; Daniel Clarke-Pearson; Robert A Burger; Robert S Mannel; Koen DeGeest; Ellen M Hartenbach; Rebecca Baergen
Journal:  J Clin Oncol       Date:  2003-07-14       Impact factor: 44.544

Review 6.  Endometriosis and the development of malignant tumours of the pelvis. A review of literature.

Authors:  Toon Van Gorp; Frederic Amant; Patrick Neven; Ignace Vergote; Phillipe Moerman
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-04       Impact factor: 5.237

Review 7.  Accuracy of magnetic resonance in deeply infiltrating endometriosis: a systematic review and meta-analysis.

Authors:  Lídia Rossi Medeiros; Maria Inês Rosa; Bruno Rosa Silva; Maria Eduarda Reis; Carla Sasso Simon; Eduardo Ronconi Dondossola; João Sabino da Cunha Filho
Journal:  Arch Gynecol Obstet       Date:  2014-10-07       Impact factor: 2.344

Review 8.  [Bowel endometriosis: a benign disease?].

Authors:  Marco Antonio Bassi; Sérgio Podgaec; João Antonio Dias Júnior; Carlos Walter Sobrado; Nicolau D Amico Filho
Journal:  Rev Assoc Med Bras (1992)       Date:  2009 Sep-Oct       Impact factor: 1.209

9.  Malignant endometriosis; pelvic endometriosis complicated by polypoid endometrioma of the colon and endometriotic sarcoma; report of a case and review of the literature.

Authors:  L R FERRARO; H HETZ; H CARTER
Journal:  Obstet Gynecol       Date:  1956-01       Impact factor: 7.661

10.  A Case of Endometrioid Adenocarcinoma Originating from the Serous Surface of the Small Intestine.

Authors:  Natsuko Makihara; Ichiro Fujita; Hiroo Soudaf; Takahisa Yamamoto; Terumasa Sashikata; Toru Mukohara; Tetsuo Maeda
Journal:  Rare Tumors       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.